Provided by Tiger Fintech (Singapore) Pte. Ltd.

TG Therapeutics

34.86
-2.8200-7.48%
Pre-market: 35.100.2400+0.69%05:19 EDT
Volume:5.43M
Turnover:190.50M
Market Cap:5.53B
PE:232.40
High:37.27
Open:37.27
Low:34.03
Close:37.68
Loading ...
Nov 04, 2021

Major Issues Report

8-K - Current report
Aug 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2021

Major Issues Report

8-K - Current report
Jun 23, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Apr 16, 2021

Major Issues Report

8-K - Current report
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Major Issues Report

8-K - Current report
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Major Issues Report

8-K - Current report